Diabetes Care · 2013 · 68 citations · 34 references
MedicineGeriatric MedicineNeurologyAgingCognitive NeurologyGeriatric AssessmentCognitive AgingCognitive AssessmentCognitive DeclineCognitive ImpairmentDiabetes MellitusAge-related Cognitive Decline AssessmentAnkle-brachial Index AssessmentCognitive Change ProcessesDiabetes-related Cognitive DeclineGeriatric Cognitive AssessmentLongitudinal Cognitive DeclineOlder Adult PopulationStroke Risk Stratification
OBJECTIVE: Macrovascular disease may contribute to increased risk of accelerated cognitive decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive change in a cognitively healthy older population with type 2 diabetes. RESEARCH DESIGN AND METHODS: Eight hundred thirty-one men and women (aged 60-75 years) attended two waves of the prospective Edinburgh Type 2 Diabetes Study (ET2DS). At baseline, clinical and subclinical macrovascular disease was measured, including cardiovascular event history, carotid intima-media thickness (cIMT), ankle brachial index (ABI), and serum N-terminal probrain natriuretic peptide (NT-proBNP). Seven neuropsychological tests were administered at baseline and after 4 years; scores were combined to a standardized general ability factor (g). Adjustment of follow-up g for baseline g assessed 4-year cognitive change. Adjustment for vocabulary (estimated premorbid ability) was used to estimate lifetime cognitive change. RESULTS: Measures of cognitive decline were significantly associated with stroke, NT-proBNP, ABI, and cIMT, but not with nonstroke vascular events. The association of stroke with increased estimated lifetime cognitive decline (standardized β, -0.12) and of subclinical markers with actual 4-year decline (standardized β, -0.12, 0.12, and -0.15 for NT-proBNP, ABI, and cIMT, respectively) reached the Bonferroni-adjusted level of statistical significance (P < 0.006). Results altered only slightly on adjustment for vascular risk factors. CONCLUSIONS: Stroke and subclinical markers of cardiac stress and generalized atherosclerosis are associated with cognitive decline in older patients with type 2 diabetes. Further investigation into the potential use of subclinical vascular disease markers in predicting cognitive decline is warranted.
34
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
The Hospital Anxiety and Depression Scale
A. S. Zigmond, R. P. Snaith · Acta Psychiatrica Scandinavica · 1983 · 46.6K citations
Older Adults' Reasons for Using Technology while Aging in Place
Sebastiaan Theodorus Michaël Peek, Katrien Luijkx, M. D. Rijnaard et al. · Gerontology · 2015 · 19.7K citations · Full text